Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 2/2005

01-06-2005

Referrals of patients to colorectal cancer genetics services in south-east Scotland

Authors: Susan Holloway, Mary Porteous, Roseanne Cetnarskyj, Robert Rush, Sally Appleton, Dermot Gorman, Harry Campbell

Published in: Familial Cancer | Issue 2/2005

Login to get access
Metadata
Title
Referrals of patients to colorectal cancer genetics services in south-east Scotland
Authors
Susan Holloway
Mary Porteous
Roseanne Cetnarskyj
Robert Rush
Sally Appleton
Dermot Gorman
Harry Campbell
Publication date
01-06-2005
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 2/2005
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-004-4488-y

Other articles of this Issue 2/2005

Familial Cancer 2/2005 Go to the issue

OriginalPaper

The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds

Review

Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers

OriginalPaper

SISE matters: the Sum of Information on Seventy-yr-old Equivalents measures pedigree information content when assessing the risk of HNPCC in a family

OriginalPaper

Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH

OriginalPaper

High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia

OriginalPaper

An unusual case of Turcot’s syndrome associated with ileal adenocarcinoma, intestinal non-Hodgkin’s lymphoma, and duodenal adenocarcinoma. Review of the classification and genetic basis of Turcot’s syndrome
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits